GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.

Oncotarget · 2016 · PMC5363591 · PMID 27764800

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp-value=6.0×10 −12actually significant

The search for variants associated with ER status showed only one region with a highly significant association, corresponding to FGFR2 (best p-value for rs3135718 p-value=6.0×10 −12 , Figure 1 and Supplementary Figure S1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.